Cancer Immunotherapy EXPLAINED

Cancer treatment has been revolutionized by immunotherapy, but how do these drugs actually work—and who benefits the most? In this video, I break down immune checkpoint inhibitors, including anti–PD-1, PD-L1, CTLA-4, and LAG-3 therapies, in a clear and practical way for patients, students, and healthcare professionals. In this video, you’ll learn: - How immune checkpoint inhibitors activate your immune system against cancer - The differences between PD-1, PD-L1, CTLA-4, and LAG-3 pathways - Common and serious immune-related adverse events (irAEs) - How side effects are recognized and managed clinically - Key predictors of response, including MSI-H and dMMR status - When immunotherapy may not be appropriate (contraindications) - The role of combining immunotherapy with chemotherapy Whether you’re a patient trying to understand your treatment options or a clinician looking for a concise review, this video provides a high-yield, real-world overview of one of the most important advances in oncology. #cancerimmunotherapy #cancertreatment #immunotherapy #talkingcancer This content is for educational purposes only and does not replace professional medical advice. Always consult your healthcare provider for personalized recommendations.